X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

COVID-19 Hospitalizations Reach An All-Time Low In The US

Content Team by Content Team
11th April 2022
in News
FDA Grants Fast Track Designation to CERC-002 for Treatment of Hospitalized Patients with COVID-19

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

There are 16,138 people in hospitals with COVID-19 as of April 8, which is the lowest number since the US Department of Health and Human Services began tracking in July 2020. Only 2% of beds are now allocated to COVID-19 users.

The previous low point occurred in late June 2021, right before Delta became the country’s main variant. COVID-19 admissions peaked in January 2022, during the Omicron outbreak, when over 160,000 people were admitted to hospitals with the virus. While the load on the US hospital system directly tied to treating COVID-19 patients has been greatly eased, experts say many hospitals are still dealing with understaffing and also other patients who are arriving sicker after postponing treatment during the peak of the pandemic.

Nancy Foster, Vice President for Quality and Patient Safety Policy at the American Hospital Association, says she can’t hear hospitalisation data without shouting “hallelujah.”However, there are a number of things going on right now that keep hospitals and their employees incredibly busy, she adds. Nancy opines that hospitals were expecting an inflow of patients who had postponed treatment, whether by preference or because the medical centre couldn’t handle them. But according to her, the biggest challenge right now is the combination of having more individuals needing care than they expected and having more staff shortages than they anticipated.

The COVID-19 Community Level map by the CDC, which monitors new hospitalizations and beds in use particularly for COVID-19 patients, stands in contrast with the overall picture of hospital capacity. The CDC map is almost entirely green, with 95 percent of US states classified as having a minimal COVID-19 community level. However, according to HHS data, upwards of three-quarters of inpatient beds are presently in use in medical centers, with nine states having more than 80% of all beds occupied. Experts think it’s critical to keep an eye on both overall hospital capability and the load posed by COVID-19.

From an endemic monitoring standpoint of COVID-19, that is where they aim to be heading. One needs to be able to detect whether there is a state where public health measures are required, says Kaiser Permanente’s national infectious disease leader, Dr. Stephen Parodi.

However, the pandemic has had a massive effect on how hospitals operate. Prior to the pandemic, there was usually a seasonal difference in how many beds were occupied, with more patients anticipated during the flu season in the winter and a lower volume expected during the summer.

What’s different today, after the pandemic, is that hospitals are essentially always filled, Parodi explained. When it concerns staffing those beds, having the workforce accessible, the doctors, nurses, and support services like lab and radiology, that computation of a plan is shifting our thinking on what we need to prepare for the full year rather than just one season.

According to Parodi and others, the capacity crunch will last at a minimum until the end of the year. According to CDC data, there have been around 4.6 million cumulative hospitalizations for COVID-19 in the United States through August 2020. Seniors aged 70 and up account for more than a third of all hospital admissions. COVID-19 has hospitalised more than twice as many black and Hispanic people as white people, and American Indians have been hospitalised more than three times as often.

Previous Post

Pfizer and BioNTech Receive Expanded U.S. EUA for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older

Next Post

Major Success Factors For Clinical Development Organizations

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

Major Success Factors For Clinical Development Organizations

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In